Chronic lymphocytic leukemia (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Chronic lymphocytic leukemia" in English language version.

refsWebsite

Global rank English rank

92nih.gov

4^th place

67doi.org

2^nd place

24semanticscholar.org

11^th place

8^th place

6worldcat.org

5^th place

4web.archive.org

1^st place

3cancer.gov

1,684^th place

1,350^th place

2books.google.com

3^rd place

2cancer.org

3,680^th place

2,918^th place

2handle.net

102^nd place

76^th place

2lecturio.com

5,619^th place

2,948^th place

2harvard.edu

18^th place

17^th place

1cancer.ca

low place

1archive.org

6^th place

1mhmedical.com

6,846^th place

4,957^th place

1accessmedicine.com

low place

1icgc.org

low place

1onclive.com

low place

1bmj.com

1,226^th place

1,421^st place

1cancerresearchuk.org

8,489^th place

6,122^nd place

1clevelandclinic.org

4,925^th place

3,597^th place

1upenn.edu

702^nd place

520^th place

1retractionwatch.com

low place

1npr.org

92^nd place

72^nd place

1nbcnews.com

137^th place

101^st place

1webmd.com

1,169^th place

1,075^th place

1reuters.com

49^th place

47^th place

1bloodjournal.org

low place

accessmedicine.com

"T Cell Prolymphocytic Leukemia". AccessMedicine. Archived from the original on 2011-07-07. Retrieved 2009-02-04.

archive.org

Bain, Barbara J. (2006). Blood Cells: A Practical Guide. Blackwell Publishing Limited. p. 439. ISBN 978-1-4051-4265-6.

bloodjournal.org

Munir T, Rawstron A, Brock K, Vicente S, Yates F, Bishop R, et al. (2017-12-07). "Initial Results of Ibrutinib Plus Venetoclax in Relapsed, Refractory CLL (Bloodwise TAP CLARITY Study): High Rates of Overall Response, Complete Remission and MRD Eradication after 6 Months of Combination Therapy". Blood. 130 (Suppl 1): 428.

bmj.com

bestpractice.bmj.com

"Chronic lymphocytic leukaemia – Symptoms, diagnosis and treatment | BMJ Best Practice". bestpractice.bmj.com. Retrieved 2021-11-29.

books.google.com

O'Brien S, Gribben JG (2008). Chronic Lymphocytic Leukemia. CRC Press. p. 19. ISBN 9781420068962.
Ferri FF (2017). Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1. Elsevier Health Sciences. p. 750. ISBN 9780323529570.

cancer.ca

"Genes and Cancer". Archived from the original on 2021-11-16.

cancer.gov

seer.cancer.gov

"Chronic Lymphocytic Leukemia – Cancer Stat Facts". seer.cancer.gov. Retrieved 9 September 2022.
"Chronic Lymphocytic Leukemia – Cancer Stat Facts". SEER. Retrieved 2020-12-07.

cancer.gov

"Chronic Lymphocytic Leukemia Treatment". National Cancer Institute. 26 October 2017. Retrieved 19 December 2017.

cancer.org

"Key Statistics for Chronic Lymphocytic Leukemia". www.cancer.org. Retrieved 2021-11-29.
"Cancer Facts & Figures 2021" (PDF). American Cancer Society. Archived (PDF) from the original on 2021-01-12.

cancerresearchuk.org

"Chronic lymphocytic leukaemia (CLL) statistics". Cancer Research UK. Retrieved 27 October 2014.

clevelandclinic.org

my.clevelandclinic.org

"Chronic Lymphocytic Leukemia". Cleveland Clinic. Retrieved 9 July 2021.

doi.org

Kipps TJ, Stevenson FK, Wu CJ, Croce CM, Packham G, Wierda WG, et al. (January 2017). "Chronic lymphocytic leukaemia". Nature Reviews. Disease Primers. 3: 16096. doi:10.1038/nrdp.2016.96. PMC 5336551. PMID 28102226.
Vos, Theo; et al. (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang, Haidong; et al. (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Hallek M, Shanafelt TD, Eichhorst B (April 2018). "Chronic lymphocytic leukaemia". Lancet. 391 (10129): 1524–1537. doi:10.1016/S0140-6736(18)30422-7. PMID 29477250. S2CID 3517733.
Stilgenbauer S, Furman RR, Zent CS (2015-05-01). "Management of chronic lymphocytic leukemia". American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting (35): 164–175. doi:10.14694/EdBook_AM.2015.35.164. PMID 25993154.
Hallek M (November 2019). "Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment". American Journal of Hematology. 94 (11): 1266–1287. doi:10.1002/ajh.25595. PMID 31364186. S2CID 199000131.
Patel K, Pagel JM (April 2021). "Current and future treatment strategies in chronic lymphocytic leukemia". Journal of Hematology & Oncology. 14 (1): 69. doi:10.1186/s13045-021-01054-w. PMC 8074228. PMID 33902665.
Hallek M (September 2017). "Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment". American Journal of Hematology. 92 (9): 946–965. doi:10.1002/ajh.24826. PMID 28782884.
Grywalska E, Zaborek M, Łyczba J, Hrynkiewicz R, Bębnowska D, Becht R, et al. (November 2020). "Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review". Cells. 9 (11): 2398. doi:10.3390/cells9112398. PMC 7693361. PMID 33147729.
Kreuzberger N, Damen JA, Trivella M, Estcourt LJ, Aldin A, Umlauff L, et al. (July 2020). "Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis". The Cochrane Database of Systematic Reviews. 2020 (7): CD012022. doi:10.1002/14651858.CD012022.pub2. PMC 8078230. PMID 32735048.
Rai KR, Jain P (March 2016). "Chronic lymphocytic leukemia (CLL)-Then and now". American Journal of Hematology. 91 (3): 330–340. doi:10.1002/ajh.24282. PMID 26690614.
Jaffe ES (January 2019). "Diagnosis and classification of lymphoma: Impact of technical advances". Seminars in Hematology. 56 (1): 30–36. doi:10.1053/j.seminhematol.2018.05.007. PMC 7394061. PMID 30573042.
Angelillo P, Capasso A, Ghia P, Scarfò L (December 2018). "Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?". European Journal of Internal Medicine. 58: 2–6. doi:10.1016/j.ejim.2018.09.006. PMID 30268574. S2CID 52892403.
Tresckow JV, Eichhorst B, Bahlo J, Hallek M (January 2019). "The Treatment of Chronic Lymphatic Leukemia". Deutsches Ärzteblatt International. 116 (4): 41–46. doi:10.3238/arztebl.2019.0041. PMC 6415618. PMID 30855005.
Choi SM, O'Malley DP (December 2018). "Diagnostically relevant updates to the 2017 WHO classification of lymphoid neoplasms". Annals of Diagnostic Pathology. 37: 67–74. doi:10.1016/j.anndiagpath.2018.09.011. PMID 30308438. S2CID 52963674.
Sigmund AM, Kittai AS (August 2022). "Richter's Transformation". Current Oncology Reports. 24 (8): 1081–1090. doi:10.1007/s11912-022-01274-4. PMID 35384590. S2CID 247975378.
D'Addona M, Giudice V, Pezzullo L, Ciancia G, Baldi C, Gorrese M, Bertolini A, Campana A, Fresolone L, Manzo P, Zeppa P, Serio B, Selleri C (August 2022). "Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review". Journal of Clinical Medicine. 11 (16): 4674. doi:10.3390/jcm11164674. PMC 9410146. PMID 36012912.
Liu H, Miao Y, Ferrajoli A, Tang G, McDonnell T, Medeiros LJ, Hu S (March 2020). "Leukemic phase of Richter transformation: A mimic of acute myeloid leukemia that responded to Ibrutinib monotherapy". American Journal of Hematology. 95 (10): 1221–1223. doi:10.1002/ajh.25782. PMID 32162729. S2CID 212677249.
Trimech M, Letourneau A, Missiaglia E, De Prijck B, Nagy-Hulliger M, Somja J, Vivario M, Gaulard P, Lambert F, Bisig B, de Leval L (June 2021). "Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome". The American Journal of Surgical Pathology. 45 (6): 773–786. doi:10.1097/PAS.0000000000001646. hdl:2268/289883. PMID 33739791. S2CID 232301854.
Travis LB, Curtis RE, Hankey BF, Fraumeni JF (September 1992). "Second cancers in patients with chronic lymphocytic leukemia". Journal of the National Cancer Institute. 84 (18): 1422–7. doi:10.1093/jnci/84.18.1422. PMID 1512794.
Kumar V, Ailawadhi S, Bojanini L, Mehta A, Biswas S, Sher T, Roy V, Vishnu P, Marin-Acevedo J, Alegria VR, Paulus A, Aulakh S, Iqbal M, Manochakian R, Tan W, Chanan-Khan A, Ailawadhi M (September 2019). "Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia". Blood Cancer Journal. 9 (10): 75. doi:10.1038/s41408-019-0237-1. PMC 6768881. PMID 31570695.
Soilleux EJ, Wotherspoon A, Eyre TA, Clifford R, Cabes M, Schuh AH (December 2016). "Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review". Histopathology. 69 (6): 1066–1076. doi:10.1111/his.13024. PMID 27345622. S2CID 205171057.
Tsimberidou AM, Keating MJ (January 2005). "Richter syndrome: biology, incidence, and therapeutic strategies". Cancer. 103 (2): 216–228. doi:10.1002/cncr.20773. PMID 15578683. S2CID 21552054.
Jarošová M, Plevová K, Kotašková J, Doubek M, Pospíšilová Š (October 2019). "The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature". Leukemia & Lymphoma. 60 (10): 2348–2355. doi:10.1080/10428194.2019.1576038. PMID 30773964. S2CID 73483725.
Sava GP, Speedy HE, Houlston RS (January 2014). "Candidate gene association studies and risk of chronic lymphocytic leukemia: a systematic review and meta-analysis". Leukemia & Lymphoma. 55 (1): 160–167. doi:10.3109/10428194.2013.800197. PMID 23647060. S2CID 207510537.
Delgado J, Nadeu F, Colomer D, Campo E (September 2020). "Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies". Haematologica. 105 (9): 2205–2217. doi:10.3324/haematol.2019.236000. PMC 7556519. PMID 33054046.
Strati P, Jain N, O'Brien S (May 2018). "Chronic Lymphocytic Leukemia: Diagnosis and Treatment". Mayo Clinic Proceedings (Review). 93 (5): 651–664. doi:10.1016/j.mayocp.2018.03.002. PMID 29728204.
Patteson AE, Carroll RJ, Iwamoto DV, Janmey PA (December 2020). "The vimentin cytoskeleton: when polymer physics meets cell biology". Physical Biology. 18 (1): 011001. doi:10.1088/1478-3975/abbcc2. PMC 8240483. PMID 32992303.
Roepman, P.; Boots, C. M.; Scheidel, K. C.; Sprong, T.; De Bruin, P.; De Weerdt, O.; Groenen, P. J.; Kummer, J. A. (2016). "Molecular clonality assessment shows high performance to predict malignant B-cell non-Hodgkin's lymphoma using cytological smears". Journal of Clinical Pathology. 69 (12): 1109–1115. doi:10.1136/jclinpath-2016-203757. PMID 27169754. S2CID 30952923.
Deans JP, Polyak MJ (February 2008). "FMC7 is an epitope of CD20". Blood. 111 (4): 2492, author reply 2493-2492, author reply 2494. doi:10.1182/blood-2007-11-126243. PMID 18263793.
Palumbo GA, Parrinello N, Fargione G, Cardillo K, Chiarenza A, Berretta S, et al. (September 2009). "CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia". Leukemia Research. 33 (9): 1212–1216. doi:10.1016/j.leukres.2009.01.017. PMID 19230971.
Zare H, Bashashati A, Kridel R, Aghaeepour N, Haffari G, Connors JM, et al. (January 2012). "Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma". American Journal of Clinical Pathology. 137 (1): 75–85. doi:10.1309/AJCPMMLQ67YOMGEW. PMC 4090220. PMID 22180480.
Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (August 1975). "Clinical staging of chronic lymphocytic leukemia". Blood. 46 (2): 219–234. doi:10.1182/blood.V46.2.219.219. PMID 1139039.
Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. (July 1981). "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis". Cancer. 48 (1): 198–206. doi:10.1002/1097-0142(19810701)48:1<198::aid-cncr2820480131>3.0.co;2-v. PMID 7237385. S2CID 38619478.
Lehmann S, Ogawa S, Raynaud SD, Sanada M, Nannya Y, Ticchioni M, et al. (March 2008). "Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia". Cancer. 112 (6): 1296–1305. doi:10.1002/cncr.23270. PMID 18246537. S2CID 205651767.
Sargent R, Jones D, Abruzzo LV, Yao H, Bonderover J, Cisneros M, et al. (January 2009). "Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia". The Journal of Molecular Diagnostics. 11 (1): 25–34. doi:10.2353/jmoldx.2009.080037. PMC 2607562. PMID 19074592.
Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, et al. (January 2004). "Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations". Proceedings of the National Academy of Sciences of the United States of America. 101 (4): 1039–1044. Bibcode:2004PNAS..101.1039S. doi:10.1073/pnas.0304717101. PMC 327147. PMID 14730057.
Pfeifer D, Pantic M, Skatulla I, Rawluk J, Kreutz C, Martens UM, et al. (February 2007). "Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays". Blood. 109 (3): 1202–1210. doi:10.1182/blood-2006-07-034256. PMID 17053054.
Gunn SR, Mohammed MS, Gorre ME, Cotter PD, Kim J, Bahler DW, et al. (September 2008). "Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia". The Journal of Molecular Diagnostics. 10 (5): 442–451. doi:10.2353/jmoldx.2008.080033. PMC 2518739. PMID 18687794.
Ascani S, Leoni P, Fraternali Orcioni G, Bearzi I, Piccioli M, Materazzi M, et al. (June 1999). "T-cell prolymphocytic leukaemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature". Annals of Oncology. 10 (6): 649–653. doi:10.1023/A:1008349422735. PMID 10442186.
Sud A, Dearden C (April 2017). "T-cell Prolymphocytic Leukemia". Hematology/Oncology Clinics of North America. 31 (2): 273–283. doi:10.1016/j.hoc.2016.11.010. PMID 28340878.
Langer-Safer PR, Levine M, Ward DC (July 1982). "Immunological method for mapping genes on Drosophila polytene chromosomes". Proceedings of the National Academy of Sciences of the United States of America. 79 (14): 4381–4385. Bibcode:1982PNAS...79.4381L. doi:10.1073/pnas.79.14.4381. PMC 346675. PMID 6812046.
Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al. (June 2018). "iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL". Blood. 131 (25): 2745–2760. doi:10.1182/blood-2017-09-806398. PMID 29540348. S2CID 206956090.
Eichhorst BF, Busch R, Hopfinger G, Pasold R, Hensel M, Steinbrecher C, et al. (February 2006). "Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia". Blood. 107 (3): 885–891. doi:10.1182/blood-2005-06-2395. PMID 16219797.
Byrd JC, Peterson BL, Morrison VA, Park K, Jacobson R, Hoke E, et al. (January 2003). "Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)". Blood. 101 (1): 6–14. doi:10.1182/blood-2002-04-1258. PMID 12393429.
Keating MJ, O'Brien S, Albitar M, Lerner S, Plunkett W, Giles F, et al. (June 2005). "Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia". Journal of Clinical Oncology. 23 (18): 4079–4088. doi:10.1200/JCO.2005.12.051. PMID 15767648.
Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. (December 2000). "Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia". The New England Journal of Medicine. 343 (24): 1750–1757. doi:10.1056/NEJM200012143432402. PMID 11114313.
Steurer M, Pall G, Richards S, Schwarzer G, Bohlius J, Greil R (July 2006). Steurer M (ed.). "Purine antagonists for chronic lymphocytic leukaemia". The Cochrane Database of Systematic Reviews. 3 (3): CD004270. doi:10.1002/14651858.CD004270.pub2. PMC 8407449. PMID 16856041.
Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J, et al. (October 2010). "Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial". Lancet. 376 (9747): 1164–1174. doi:10.1016/S0140-6736(10)61381-5. PMID 20888994. S2CID 28834830.
Khan M, Siddiqi T (December 2018). "Targeted Therapies in CLL: Monotherapy Versus Combination Approaches". Current Hematologic Malignancy Reports. 13 (6): 525–533. doi:10.1007/s11899-018-0481-7. PMID 30535947. S2CID 54473182.
Gribben JG (January 2009). "Stem cell transplantation in chronic lymphocytic leukemia". Biology of Blood and Marrow Transplantation. 15 (1 Suppl): 53–58. doi:10.1016/j.bbmt.2008.10.022. PMC 2668540. PMID 19147079.
Dreger P, Brand R, Hansz J, Milligan D, Corradini P, Finke J, et al. (May 2003). "Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning". Leukemia. 17 (5): 841–848. doi:10.1038/sj.leu.2402905. PMID 12750695. S2CID 10144544.
Molica S, Giannarelli D, Mirabelli R, Levato L, Shanafelt TD (July 2019). "The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis". Leukemia & Lymphoma. 60 (7): 1644–1649. doi:10.1080/10428194.2018.1543882. PMID 30516079. S2CID 54544330.
Shapira T, Pereg D, Lishner M (September 2008). "How I treat acute and chronic leukemia in pregnancy". Blood Reviews. 22 (5): 247–259. doi:10.1016/j.blre.2008.03.006. PMID 18472198.
Bosch F, Dalla-Favera R (November 2019). "Chronic lymphocytic leukaemia: from genetics to treatment". Nature Reviews. Clinical Oncology. 16 (11): 684–701. doi:10.1038/s41571-019-0239-8. PMID 31278397. S2CID 195804409.
Rossi D, Lobetti Bodoni C, Genuardi E, Monitillo L, Drandi D, Cerri M, et al. (June 2009). "Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia". Leukemia. 23 (6): 1062–1072. doi:10.1038/leu.2008.399. hdl:2434/663837. PMID 19340005.
Al-Sawaf O, Robrecht S, Bahlo J, Fink AM, Cramer P, von Tresckow J, et al. (October 2017). "Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group". Leukemia. 31 (10): 2251–2253. doi:10.1038/leu.2017.221. PMID 28745332. S2CID 6542508.
Rawstron AC, Green MJ, Kuzmicki A, Kennedy B, Fenton JA, Evans PA, et al. (July 2002). "Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts". Blood. 100 (2): 635–639. doi:10.1182/blood.V100.2.635. PMID 12091358.
Shanshal M, Haddad RY (April 2012). "Chronic lymphocytic leukemia". Disease-a-Month. 58 (4): 153–167. doi:10.1016/j.disamonth.2012.01.009. PMID 22449365.
Boonhat H, Lin RT (December 2020). "Association between leukemia incidence and mortality and residential petrochemical exposure: A systematic review and meta-analysis". Environment International. 145: 106090. doi:10.1016/j.envint.2020.106090. PMID 32932064. S2CID 221748665.
Pérez-Carretero C, González-Gascón-Y-Marín I, Rodríguez-Vicente AE, Quijada-Álamo M, Hernández-Rivas JÁ, Hernández-Sánchez M, Hernández-Rivas JM (May 2021). "The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment". Diagnostics. 11 (5): 853. doi:10.3390/diagnostics11050853. PMC 8151186. PMID 34068813.
Kharfan-Dabaja MA, Kumar A, Hamadani M, Stilgenbauer S, Ghia P, Anasetti C, et al. (December 2016). "Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation". Biology of Blood and Marrow Transplantation. 22 (12): 2117–2125. doi:10.1016/j.bbmt.2016.09.013. PMC 5116249. PMID 27660167.
Porter DL, Levine BL, Kalos M, Bagg A, June CH (August 2011). "Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia". The New England Journal of Medicine. 365 (8): 725–733. doi:10.1056/NEJMoa1103849. PMC 3387277. PMID 21830940. (Erratum: doi:10.1056/NEJMx160005, PMID 26962747, Retraction Watch. If the erratum has been checked and does not affect the cited material, please replace {{erratum|...}} with {{erratum|...|checked=yes}}.)
Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH (August 2011). "T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia". Science Translational Medicine. 3 (95): 95ra73. doi:10.1126/scitranslmed.3002842. PMC 3393096. PMID 21832238.
ten Hacken E, Burger JA (December 2014). "Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapies". Pharmacology & Therapeutics. 144 (3): 338–348. doi:10.1016/j.pharmthera.2014.07.003. PMID 25050922.
Farooqui AA, Ashraf A, Farooq TB, Anjum A, Rehman SU, Akbar A, et al. (July 2020). "Novel Targeted Therapies for Chronic Lymphocytic Leukemia in Elderly Patients: A Systematic Review". Clinical Lymphoma, Myeloma & Leukemia. 20 (7): e414–e426. doi:10.1016/j.clml.2020.02.013. PMID 32291235. S2CID 213941348.
Cao JX, Gao WJ, You J, Wu LH, Liu JL, Wang ZX (July 2019). "The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies". Cytotherapy. 21 (7): 769–781. doi:10.1016/j.jcyt.2019.04.005. PMID 31160157. S2CID 174808115.

handle.net

hdl.handle.net

Trimech M, Letourneau A, Missiaglia E, De Prijck B, Nagy-Hulliger M, Somja J, Vivario M, Gaulard P, Lambert F, Bisig B, de Leval L (June 2021). "Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome". The American Journal of Surgical Pathology. 45 (6): 773–786. doi:10.1097/PAS.0000000000001646. hdl:2268/289883. PMID 33739791. S2CID 232301854.
Rossi D, Lobetti Bodoni C, Genuardi E, Monitillo L, Drandi D, Cerri M, et al. (June 2009). "Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia". Leukemia. 23 (6): 1062–1072. doi:10.1038/leu.2008.399. hdl:2434/663837. PMID 19340005.

harvard.edu

ui.adsabs.harvard.edu

Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, et al. (January 2004). "Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations". Proceedings of the National Academy of Sciences of the United States of America. 101 (4): 1039–1044. Bibcode:2004PNAS..101.1039S. doi:10.1073/pnas.0304717101. PMC 327147. PMID 14730057.
Langer-Safer PR, Levine M, Ward DC (July 1982). "Immunological method for mapping genes on Drosophila polytene chromosomes". Proceedings of the National Academy of Sciences of the United States of America. 79 (14): 4381–4385. Bibcode:1982PNAS...79.4381L. doi:10.1073/pnas.79.14.4381. PMC 346675. PMID 6812046.

icgc.org

"France – Lymphoproliferative Syndrome B-Cell Prolymphocytic Leukemia |". icgc.org. Retrieved 2016-11-18.

lecturio.com

"Chronic Lymphocytic Leukemia". The Lecturio Medical Concept Library. Retrieved 9 July 2021.
"Hairy Cell Leukemia". The Lecturio Medical Concept Library. Retrieved 24 July 2021.

mhmedical.com

accessmedicine.mhmedical.com

Woyach, Jennifer A.; Byrd, John C. (2022), Loscalzo, J; Fauci, Anthony S.; Kasper, Dennis L.; Hauser, Stephen L.; Longo, D; Jameson, J (eds.), "Chronic Lymphocytic Leukemia", Harrison's Principles of Internal Medicine (21 ed.), New York, NY: McGraw-Hill Education, retrieved 2023-01-29

nbcnews.com

Bazell R (August 10, 2011). "New leukemia treatment exceeds 'wildest expectations'". NBC News. Archived from the original on March 5, 2013. Retrieved August 12, 2011.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kipps TJ, Stevenson FK, Wu CJ, Croce CM, Packham G, Wierda WG, et al. (January 2017). "Chronic lymphocytic leukaemia". Nature Reviews. Disease Primers. 3: 16096. doi:10.1038/nrdp.2016.96. PMC 5336551. PMID 28102226.
Vos, Theo; et al. (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang, Haidong; et al. (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Boelens J, Lust S, Vanhoecke B, Offner F (February 2009). "Chronic lymphocytic leukaemia". Anticancer Research. 29 (2): 605–615. PMID 19331210.
Hallek M, Shanafelt TD, Eichhorst B (April 2018). "Chronic lymphocytic leukaemia". Lancet. 391 (10129): 1524–1537. doi:10.1016/S0140-6736(18)30422-7. PMID 29477250. S2CID 3517733.
Stilgenbauer S, Furman RR, Zent CS (2015-05-01). "Management of chronic lymphocytic leukemia". American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting (35): 164–175. doi:10.14694/EdBook_AM.2015.35.164. PMID 25993154.
Hallek M (November 2019). "Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment". American Journal of Hematology. 94 (11): 1266–1287. doi:10.1002/ajh.25595. PMID 31364186. S2CID 199000131.
Patel K, Pagel JM (April 2021). "Current and future treatment strategies in chronic lymphocytic leukemia". Journal of Hematology & Oncology. 14 (1): 69. doi:10.1186/s13045-021-01054-w. PMC 8074228. PMID 33902665.
Hallek M (September 2017). "Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment". American Journal of Hematology. 92 (9): 946–965. doi:10.1002/ajh.24826. PMID 28782884.
Grywalska E, Zaborek M, Łyczba J, Hrynkiewicz R, Bębnowska D, Becht R, et al. (November 2020). "Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review". Cells. 9 (11): 2398. doi:10.3390/cells9112398. PMC 7693361. PMID 33147729.
Kreuzberger N, Damen JA, Trivella M, Estcourt LJ, Aldin A, Umlauff L, et al. (July 2020). "Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis". The Cochrane Database of Systematic Reviews. 2020 (7): CD012022. doi:10.1002/14651858.CD012022.pub2. PMC 8078230. PMID 32735048.
Rai KR, Jain P (March 2016). "Chronic lymphocytic leukemia (CLL)-Then and now". American Journal of Hematology. 91 (3): 330–340. doi:10.1002/ajh.24282. PMID 26690614.
Jaffe ES (January 2019). "Diagnosis and classification of lymphoma: Impact of technical advances". Seminars in Hematology. 56 (1): 30–36. doi:10.1053/j.seminhematol.2018.05.007. PMC 7394061. PMID 30573042.
Angelillo P, Capasso A, Ghia P, Scarfò L (December 2018). "Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?". European Journal of Internal Medicine. 58: 2–6. doi:10.1016/j.ejim.2018.09.006. PMID 30268574. S2CID 52892403.
Tresckow JV, Eichhorst B, Bahlo J, Hallek M (January 2019). "The Treatment of Chronic Lymphatic Leukemia". Deutsches Ärzteblatt International. 116 (4): 41–46. doi:10.3238/arztebl.2019.0041. PMC 6415618. PMID 30855005.
Choi SM, O'Malley DP (December 2018). "Diagnostically relevant updates to the 2017 WHO classification of lymphoid neoplasms". Annals of Diagnostic Pathology. 37: 67–74. doi:10.1016/j.anndiagpath.2018.09.011. PMID 30308438. S2CID 52963674.
Sigmund AM, Kittai AS (August 2022). "Richter's Transformation". Current Oncology Reports. 24 (8): 1081–1090. doi:10.1007/s11912-022-01274-4. PMID 35384590. S2CID 247975378.
D'Addona M, Giudice V, Pezzullo L, Ciancia G, Baldi C, Gorrese M, Bertolini A, Campana A, Fresolone L, Manzo P, Zeppa P, Serio B, Selleri C (August 2022). "Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review". Journal of Clinical Medicine. 11 (16): 4674. doi:10.3390/jcm11164674. PMC 9410146. PMID 36012912.
Liu H, Miao Y, Ferrajoli A, Tang G, McDonnell T, Medeiros LJ, Hu S (March 2020). "Leukemic phase of Richter transformation: A mimic of acute myeloid leukemia that responded to Ibrutinib monotherapy". American Journal of Hematology. 95 (10): 1221–1223. doi:10.1002/ajh.25782. PMID 32162729. S2CID 212677249.
Trimech M, Letourneau A, Missiaglia E, De Prijck B, Nagy-Hulliger M, Somja J, Vivario M, Gaulard P, Lambert F, Bisig B, de Leval L (June 2021). "Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome". The American Journal of Surgical Pathology. 45 (6): 773–786. doi:10.1097/PAS.0000000000001646. hdl:2268/289883. PMID 33739791. S2CID 232301854.
Travis LB, Curtis RE, Hankey BF, Fraumeni JF (September 1992). "Second cancers in patients with chronic lymphocytic leukemia". Journal of the National Cancer Institute. 84 (18): 1422–7. doi:10.1093/jnci/84.18.1422. PMID 1512794.
Kumar V, Ailawadhi S, Bojanini L, Mehta A, Biswas S, Sher T, Roy V, Vishnu P, Marin-Acevedo J, Alegria VR, Paulus A, Aulakh S, Iqbal M, Manochakian R, Tan W, Chanan-Khan A, Ailawadhi M (September 2019). "Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia". Blood Cancer Journal. 9 (10): 75. doi:10.1038/s41408-019-0237-1. PMC 6768881. PMID 31570695.
Soilleux EJ, Wotherspoon A, Eyre TA, Clifford R, Cabes M, Schuh AH (December 2016). "Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review". Histopathology. 69 (6): 1066–1076. doi:10.1111/his.13024. PMID 27345622. S2CID 205171057.
Tsimberidou AM, Keating MJ (January 2005). "Richter syndrome: biology, incidence, and therapeutic strategies". Cancer. 103 (2): 216–228. doi:10.1002/cncr.20773. PMID 15578683. S2CID 21552054.
Jarošová M, Plevová K, Kotašková J, Doubek M, Pospíšilová Š (October 2019). "The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature". Leukemia & Lymphoma. 60 (10): 2348–2355. doi:10.1080/10428194.2019.1576038. PMID 30773964. S2CID 73483725.
Sava GP, Speedy HE, Houlston RS (January 2014). "Candidate gene association studies and risk of chronic lymphocytic leukemia: a systematic review and meta-analysis". Leukemia & Lymphoma. 55 (1): 160–167. doi:10.3109/10428194.2013.800197. PMID 23647060. S2CID 207510537.
Delgado J, Nadeu F, Colomer D, Campo E (September 2020). "Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies". Haematologica. 105 (9): 2205–2217. doi:10.3324/haematol.2019.236000. PMC 7556519. PMID 33054046.
Strati P, Jain N, O'Brien S (May 2018). "Chronic Lymphocytic Leukemia: Diagnosis and Treatment". Mayo Clinic Proceedings (Review). 93 (5): 651–664. doi:10.1016/j.mayocp.2018.03.002. PMID 29728204.
Patteson AE, Carroll RJ, Iwamoto DV, Janmey PA (December 2020). "The vimentin cytoskeleton: when polymer physics meets cell biology". Physical Biology. 18 (1): 011001. doi:10.1088/1478-3975/abbcc2. PMC 8240483. PMID 32992303.
Roepman, P.; Boots, C. M.; Scheidel, K. C.; Sprong, T.; De Bruin, P.; De Weerdt, O.; Groenen, P. J.; Kummer, J. A. (2016). "Molecular clonality assessment shows high performance to predict malignant B-cell non-Hodgkin's lymphoma using cytological smears". Journal of Clinical Pathology. 69 (12): 1109–1115. doi:10.1136/jclinpath-2016-203757. PMID 27169754. S2CID 30952923.
Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D (October 1994). "The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL". Leukemia. 8 (10): 1640–1645. PMID 7523797.
Deans JP, Polyak MJ (February 2008). "FMC7 is an epitope of CD20". Blood. 111 (4): 2492, author reply 2493-2492, author reply 2494. doi:10.1182/blood-2007-11-126243. PMID 18263793.
Palumbo GA, Parrinello N, Fargione G, Cardillo K, Chiarenza A, Berretta S, et al. (September 2009). "CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia". Leukemia Research. 33 (9): 1212–1216. doi:10.1016/j.leukres.2009.01.017. PMID 19230971.
Zare H, Bashashati A, Kridel R, Aghaeepour N, Haffari G, Connors JM, et al. (January 2012). "Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma". American Journal of Clinical Pathology. 137 (1): 75–85. doi:10.1309/AJCPMMLQ67YOMGEW. PMC 4090220. PMID 22180480.
Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (August 1975). "Clinical staging of chronic lymphocytic leukemia". Blood. 46 (2): 219–234. doi:10.1182/blood.V46.2.219.219. PMID 1139039.
Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. (July 1981). "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis". Cancer. 48 (1): 198–206. doi:10.1002/1097-0142(19810701)48:1<198::aid-cncr2820480131>3.0.co;2-v. PMID 7237385. S2CID 38619478.
Lehmann S, Ogawa S, Raynaud SD, Sanada M, Nannya Y, Ticchioni M, et al. (March 2008). "Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia". Cancer. 112 (6): 1296–1305. doi:10.1002/cncr.23270. PMID 18246537. S2CID 205651767.
Sargent R, Jones D, Abruzzo LV, Yao H, Bonderover J, Cisneros M, et al. (January 2009). "Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia". The Journal of Molecular Diagnostics. 11 (1): 25–34. doi:10.2353/jmoldx.2009.080037. PMC 2607562. PMID 19074592.
Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, et al. (January 2004). "Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations". Proceedings of the National Academy of Sciences of the United States of America. 101 (4): 1039–1044. Bibcode:2004PNAS..101.1039S. doi:10.1073/pnas.0304717101. PMC 327147. PMID 14730057.
Pfeifer D, Pantic M, Skatulla I, Rawluk J, Kreutz C, Martens UM, et al. (February 2007). "Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays". Blood. 109 (3): 1202–1210. doi:10.1182/blood-2006-07-034256. PMID 17053054.
Gunn SR, Mohammed MS, Gorre ME, Cotter PD, Kim J, Bahler DW, et al. (September 2008). "Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia". The Journal of Molecular Diagnostics. 10 (5): 442–451. doi:10.2353/jmoldx.2008.080033. PMC 2518739. PMID 18687794.
Ascani S, Leoni P, Fraternali Orcioni G, Bearzi I, Piccioli M, Materazzi M, et al. (June 1999). "T-cell prolymphocytic leukaemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature". Annals of Oncology. 10 (6): 649–653. doi:10.1023/A:1008349422735. PMID 10442186.
Sud A, Dearden C (April 2017). "T-cell Prolymphocytic Leukemia". Hematology/Oncology Clinics of North America. 31 (2): 273–283. doi:10.1016/j.hoc.2016.11.010. PMID 28340878.
Langer-Safer PR, Levine M, Ward DC (July 1982). "Immunological method for mapping genes on Drosophila polytene chromosomes". Proceedings of the National Academy of Sciences of the United States of America. 79 (14): 4381–4385. Bibcode:1982PNAS...79.4381L. doi:10.1073/pnas.79.14.4381. PMC 346675. PMID 6812046.
Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al. (June 2018). "iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL". Blood. 131 (25): 2745–2760. doi:10.1182/blood-2017-09-806398. PMID 29540348. S2CID 206956090.
Eichhorst BF, Busch R, Hopfinger G, Pasold R, Hensel M, Steinbrecher C, et al. (February 2006). "Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia". Blood. 107 (3): 885–891. doi:10.1182/blood-2005-06-2395. PMID 16219797.
Byrd JC, Peterson BL, Morrison VA, Park K, Jacobson R, Hoke E, et al. (January 2003). "Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)". Blood. 101 (1): 6–14. doi:10.1182/blood-2002-04-1258. PMID 12393429.
Keating MJ, O'Brien S, Albitar M, Lerner S, Plunkett W, Giles F, et al. (June 2005). "Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia". Journal of Clinical Oncology. 23 (18): 4079–4088. doi:10.1200/JCO.2005.12.051. PMID 15767648.
Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, et al. (December 2000). "Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia". The New England Journal of Medicine. 343 (24): 1750–1757. doi:10.1056/NEJM200012143432402. PMID 11114313.
Steurer M, Pall G, Richards S, Schwarzer G, Bohlius J, Greil R (July 2006). Steurer M (ed.). "Purine antagonists for chronic lymphocytic leukaemia". The Cochrane Database of Systematic Reviews. 3 (3): CD004270. doi:10.1002/14651858.CD004270.pub2. PMC 8407449. PMID 16856041.
Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J, et al. (October 2010). "Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial". Lancet. 376 (9747): 1164–1174. doi:10.1016/S0140-6736(10)61381-5. PMID 20888994. S2CID 28834830.
Khan M, Siddiqi T (December 2018). "Targeted Therapies in CLL: Monotherapy Versus Combination Approaches". Current Hematologic Malignancy Reports. 13 (6): 525–533. doi:10.1007/s11899-018-0481-7. PMID 30535947. S2CID 54473182.
Gribben JG (January 2009). "Stem cell transplantation in chronic lymphocytic leukemia". Biology of Blood and Marrow Transplantation. 15 (1 Suppl): 53–58. doi:10.1016/j.bbmt.2008.10.022. PMC 2668540. PMID 19147079.
Dreger P, Brand R, Hansz J, Milligan D, Corradini P, Finke J, et al. (May 2003). "Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning". Leukemia. 17 (5): 841–848. doi:10.1038/sj.leu.2402905. PMID 12750695. S2CID 10144544.
Molica S, Giannarelli D, Mirabelli R, Levato L, Shanafelt TD (July 2019). "The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis". Leukemia & Lymphoma. 60 (7): 1644–1649. doi:10.1080/10428194.2018.1543882. PMID 30516079. S2CID 54544330.
Shapira T, Pereg D, Lishner M (September 2008). "How I treat acute and chronic leukemia in pregnancy". Blood Reviews. 22 (5): 247–259. doi:10.1016/j.blre.2008.03.006. PMID 18472198.
Bosch F, Dalla-Favera R (November 2019). "Chronic lymphocytic leukaemia: from genetics to treatment". Nature Reviews. Clinical Oncology. 16 (11): 684–701. doi:10.1038/s41571-019-0239-8. PMID 31278397. S2CID 195804409.
Rossi D, Lobetti Bodoni C, Genuardi E, Monitillo L, Drandi D, Cerri M, et al. (June 2009). "Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia". Leukemia. 23 (6): 1062–1072. doi:10.1038/leu.2008.399. hdl:2434/663837. PMID 19340005.
Al-Sawaf O, Robrecht S, Bahlo J, Fink AM, Cramer P, von Tresckow J, et al. (October 2017). "Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group". Leukemia. 31 (10): 2251–2253. doi:10.1038/leu.2017.221. PMID 28745332. S2CID 6542508.
Rawstron AC, Green MJ, Kuzmicki A, Kennedy B, Fenton JA, Evans PA, et al. (July 2002). "Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts". Blood. 100 (2): 635–639. doi:10.1182/blood.V100.2.635. PMID 12091358.
Shanshal M, Haddad RY (April 2012). "Chronic lymphocytic leukemia". Disease-a-Month. 58 (4): 153–167. doi:10.1016/j.disamonth.2012.01.009. PMID 22449365.
Boonhat H, Lin RT (December 2020). "Association between leukemia incidence and mortality and residential petrochemical exposure: A systematic review and meta-analysis". Environment International. 145: 106090. doi:10.1016/j.envint.2020.106090. PMID 32932064. S2CID 221748665.
Pérez-Carretero C, González-Gascón-Y-Marín I, Rodríguez-Vicente AE, Quijada-Álamo M, Hernández-Rivas JÁ, Hernández-Sánchez M, Hernández-Rivas JM (May 2021). "The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment". Diagnostics. 11 (5): 853. doi:10.3390/diagnostics11050853. PMC 8151186. PMID 34068813.
Kharfan-Dabaja MA, Kumar A, Hamadani M, Stilgenbauer S, Ghia P, Anasetti C, et al. (December 2016). "Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation". Biology of Blood and Marrow Transplantation. 22 (12): 2117–2125. doi:10.1016/j.bbmt.2016.09.013. PMC 5116249. PMID 27660167.
Porter DL, Levine BL, Kalos M, Bagg A, June CH (August 2011). "Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia". The New England Journal of Medicine. 365 (8): 725–733. doi:10.1056/NEJMoa1103849. PMC 3387277. PMID 21830940. (Erratum: doi:10.1056/NEJMx160005, PMID 26962747, Retraction Watch. If the erratum has been checked and does not affect the cited material, please replace {{erratum|...}} with {{erratum|...|checked=yes}}.)
Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH (August 2011). "T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia". Science Translational Medicine. 3 (95): 95ra73. doi:10.1126/scitranslmed.3002842. PMC 3393096. PMID 21832238.
ten Hacken E, Burger JA (December 2014). "Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapies". Pharmacology & Therapeutics. 144 (3): 338–348. doi:10.1016/j.pharmthera.2014.07.003. PMID 25050922.
Farooqui AA, Ashraf A, Farooq TB, Anjum A, Rehman SU, Akbar A, et al. (July 2020). "Novel Targeted Therapies for Chronic Lymphocytic Leukemia in Elderly Patients: A Systematic Review". Clinical Lymphoma, Myeloma & Leukemia. 20 (7): e414–e426. doi:10.1016/j.clml.2020.02.013. PMID 32291235. S2CID 213941348.
Cao JX, Gao WJ, You J, Wu LH, Liu JL, Wang ZX (July 2019). "The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies". Cytotherapy. 21 (7): 769–781. doi:10.1016/j.jcyt.2019.04.005. PMID 31160157. S2CID 174808115.

ncbi.nlm.nih.gov

Kipps TJ, Stevenson FK, Wu CJ, Croce CM, Packham G, Wierda WG, et al. (January 2017). "Chronic lymphocytic leukaemia". Nature Reviews. Disease Primers. 3: 16096. doi:10.1038/nrdp.2016.96. PMC 5336551. PMID 28102226.
Vos, Theo; et al. (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang, Haidong; et al. (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Patel K, Pagel JM (April 2021). "Current and future treatment strategies in chronic lymphocytic leukemia". Journal of Hematology & Oncology. 14 (1): 69. doi:10.1186/s13045-021-01054-w. PMC 8074228. PMID 33902665.
Grywalska E, Zaborek M, Łyczba J, Hrynkiewicz R, Bębnowska D, Becht R, et al. (November 2020). "Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review". Cells. 9 (11): 2398. doi:10.3390/cells9112398. PMC 7693361. PMID 33147729.
Kreuzberger N, Damen JA, Trivella M, Estcourt LJ, Aldin A, Umlauff L, et al. (July 2020). "Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis". The Cochrane Database of Systematic Reviews. 2020 (7): CD012022. doi:10.1002/14651858.CD012022.pub2. PMC 8078230. PMID 32735048.
Jaffe ES (January 2019). "Diagnosis and classification of lymphoma: Impact of technical advances". Seminars in Hematology. 56 (1): 30–36. doi:10.1053/j.seminhematol.2018.05.007. PMC 7394061. PMID 30573042.
Tresckow JV, Eichhorst B, Bahlo J, Hallek M (January 2019). "The Treatment of Chronic Lymphatic Leukemia". Deutsches Ärzteblatt International. 116 (4): 41–46. doi:10.3238/arztebl.2019.0041. PMC 6415618. PMID 30855005.
D'Addona M, Giudice V, Pezzullo L, Ciancia G, Baldi C, Gorrese M, Bertolini A, Campana A, Fresolone L, Manzo P, Zeppa P, Serio B, Selleri C (August 2022). "Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review". Journal of Clinical Medicine. 11 (16): 4674. doi:10.3390/jcm11164674. PMC 9410146. PMID 36012912.
Kumar V, Ailawadhi S, Bojanini L, Mehta A, Biswas S, Sher T, Roy V, Vishnu P, Marin-Acevedo J, Alegria VR, Paulus A, Aulakh S, Iqbal M, Manochakian R, Tan W, Chanan-Khan A, Ailawadhi M (September 2019). "Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia". Blood Cancer Journal. 9 (10): 75. doi:10.1038/s41408-019-0237-1. PMC 6768881. PMID 31570695.
Delgado J, Nadeu F, Colomer D, Campo E (September 2020). "Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies". Haematologica. 105 (9): 2205–2217. doi:10.3324/haematol.2019.236000. PMC 7556519. PMID 33054046.
Patteson AE, Carroll RJ, Iwamoto DV, Janmey PA (December 2020). "The vimentin cytoskeleton: when polymer physics meets cell biology". Physical Biology. 18 (1): 011001. doi:10.1088/1478-3975/abbcc2. PMC 8240483. PMID 32992303.
Zare H, Bashashati A, Kridel R, Aghaeepour N, Haffari G, Connors JM, et al. (January 2012). "Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma". American Journal of Clinical Pathology. 137 (1): 75–85. doi:10.1309/AJCPMMLQ67YOMGEW. PMC 4090220. PMID 22180480.
Sargent R, Jones D, Abruzzo LV, Yao H, Bonderover J, Cisneros M, et al. (January 2009). "Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia". The Journal of Molecular Diagnostics. 11 (1): 25–34. doi:10.2353/jmoldx.2009.080037. PMC 2607562. PMID 19074592.
Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, et al. (January 2004). "Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations". Proceedings of the National Academy of Sciences of the United States of America. 101 (4): 1039–1044. Bibcode:2004PNAS..101.1039S. doi:10.1073/pnas.0304717101. PMC 327147. PMID 14730057.
Gunn SR, Mohammed MS, Gorre ME, Cotter PD, Kim J, Bahler DW, et al. (September 2008). "Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia". The Journal of Molecular Diagnostics. 10 (5): 442–451. doi:10.2353/jmoldx.2008.080033. PMC 2518739. PMID 18687794.
Langer-Safer PR, Levine M, Ward DC (July 1982). "Immunological method for mapping genes on Drosophila polytene chromosomes". Proceedings of the National Academy of Sciences of the United States of America. 79 (14): 4381–4385. Bibcode:1982PNAS...79.4381L. doi:10.1073/pnas.79.14.4381. PMC 346675. PMID 6812046.
Steurer M, Pall G, Richards S, Schwarzer G, Bohlius J, Greil R (July 2006). Steurer M (ed.). "Purine antagonists for chronic lymphocytic leukaemia". The Cochrane Database of Systematic Reviews. 3 (3): CD004270. doi:10.1002/14651858.CD004270.pub2. PMC 8407449. PMID 16856041.
Gribben JG (January 2009). "Stem cell transplantation in chronic lymphocytic leukemia". Biology of Blood and Marrow Transplantation. 15 (1 Suppl): 53–58. doi:10.1016/j.bbmt.2008.10.022. PMC 2668540. PMID 19147079.
Pérez-Carretero C, González-Gascón-Y-Marín I, Rodríguez-Vicente AE, Quijada-Álamo M, Hernández-Rivas JÁ, Hernández-Sánchez M, Hernández-Rivas JM (May 2021). "The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment". Diagnostics. 11 (5): 853. doi:10.3390/diagnostics11050853. PMC 8151186. PMID 34068813.
Kharfan-Dabaja MA, Kumar A, Hamadani M, Stilgenbauer S, Ghia P, Anasetti C, et al. (December 2016). "Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation". Biology of Blood and Marrow Transplantation. 22 (12): 2117–2125. doi:10.1016/j.bbmt.2016.09.013. PMC 5116249. PMID 27660167.
Porter DL, Levine BL, Kalos M, Bagg A, June CH (August 2011). "Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia". The New England Journal of Medicine. 365 (8): 725–733. doi:10.1056/NEJMoa1103849. PMC 3387277. PMID 21830940. (Erratum: doi:10.1056/NEJMx160005, PMID 26962747, Retraction Watch. If the erratum has been checked and does not affect the cited material, please replace {{erratum|...}} with {{erratum|...|checked=yes}}.)
Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH (August 2011). "T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia". Science Translational Medicine. 3 (95): 95ra73. doi:10.1126/scitranslmed.3002842. PMC 3393096. PMID 21832238.

npr.org

Palca J (August 11, 2011). "Gene Therapy Advance Trains Immune System To Fight Leukemia". NPR. Retrieved August 12, 2011.

onclive.com

Janssens; et al. (2011). "Rituximab for Chronic Lymphocytic Leukemia in Treatment-Naïve and Treatment-Experienced Patients". Contemporary Oncology. 3 (3): 24–36.

retractionwatch.com

Porter DL, Levine BL, Kalos M, Bagg A, June CH (August 2011). "Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia". The New England Journal of Medicine. 365 (8): 725–733. doi:10.1056/NEJMoa1103849. PMC 3387277. PMID 21830940. (Erratum: doi:10.1056/NEJMx160005, PMID 26962747, Retraction Watch. If the erratum has been checked and does not affect the cited material, please replace {{erratum|...}} with {{erratum|...|checked=yes}}.)

reuters.com

Beasly D (August 10, 2011). "Gene therapy shown to destroy leukemia tumors". Reuters. Retrieved August 12, 2011.

semanticscholar.org

api.semanticscholar.org

Hallek M, Shanafelt TD, Eichhorst B (April 2018). "Chronic lymphocytic leukaemia". Lancet. 391 (10129): 1524–1537. doi:10.1016/S0140-6736(18)30422-7. PMID 29477250. S2CID 3517733.
Hallek M (November 2019). "Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment". American Journal of Hematology. 94 (11): 1266–1287. doi:10.1002/ajh.25595. PMID 31364186. S2CID 199000131.
Angelillo P, Capasso A, Ghia P, Scarfò L (December 2018). "Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?". European Journal of Internal Medicine. 58: 2–6. doi:10.1016/j.ejim.2018.09.006. PMID 30268574. S2CID 52892403.
Choi SM, O'Malley DP (December 2018). "Diagnostically relevant updates to the 2017 WHO classification of lymphoid neoplasms". Annals of Diagnostic Pathology. 37: 67–74. doi:10.1016/j.anndiagpath.2018.09.011. PMID 30308438. S2CID 52963674.
Sigmund AM, Kittai AS (August 2022). "Richter's Transformation". Current Oncology Reports. 24 (8): 1081–1090. doi:10.1007/s11912-022-01274-4. PMID 35384590. S2CID 247975378.
Liu H, Miao Y, Ferrajoli A, Tang G, McDonnell T, Medeiros LJ, Hu S (March 2020). "Leukemic phase of Richter transformation: A mimic of acute myeloid leukemia that responded to Ibrutinib monotherapy". American Journal of Hematology. 95 (10): 1221–1223. doi:10.1002/ajh.25782. PMID 32162729. S2CID 212677249.
Trimech M, Letourneau A, Missiaglia E, De Prijck B, Nagy-Hulliger M, Somja J, Vivario M, Gaulard P, Lambert F, Bisig B, de Leval L (June 2021). "Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome". The American Journal of Surgical Pathology. 45 (6): 773–786. doi:10.1097/PAS.0000000000001646. hdl:2268/289883. PMID 33739791. S2CID 232301854.
Soilleux EJ, Wotherspoon A, Eyre TA, Clifford R, Cabes M, Schuh AH (December 2016). "Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review". Histopathology. 69 (6): 1066–1076. doi:10.1111/his.13024. PMID 27345622. S2CID 205171057.
Tsimberidou AM, Keating MJ (January 2005). "Richter syndrome: biology, incidence, and therapeutic strategies". Cancer. 103 (2): 216–228. doi:10.1002/cncr.20773. PMID 15578683. S2CID 21552054.
Jarošová M, Plevová K, Kotašková J, Doubek M, Pospíšilová Š (October 2019). "The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature". Leukemia & Lymphoma. 60 (10): 2348–2355. doi:10.1080/10428194.2019.1576038. PMID 30773964. S2CID 73483725.
Sava GP, Speedy HE, Houlston RS (January 2014). "Candidate gene association studies and risk of chronic lymphocytic leukemia: a systematic review and meta-analysis". Leukemia & Lymphoma. 55 (1): 160–167. doi:10.3109/10428194.2013.800197. PMID 23647060. S2CID 207510537.
Roepman, P.; Boots, C. M.; Scheidel, K. C.; Sprong, T.; De Bruin, P.; De Weerdt, O.; Groenen, P. J.; Kummer, J. A. (2016). "Molecular clonality assessment shows high performance to predict malignant B-cell non-Hodgkin's lymphoma using cytological smears". Journal of Clinical Pathology. 69 (12): 1109–1115. doi:10.1136/jclinpath-2016-203757. PMID 27169754. S2CID 30952923.
Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. (July 1981). "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis". Cancer. 48 (1): 198–206. doi:10.1002/1097-0142(19810701)48:1<198::aid-cncr2820480131>3.0.co;2-v. PMID 7237385. S2CID 38619478.
Lehmann S, Ogawa S, Raynaud SD, Sanada M, Nannya Y, Ticchioni M, et al. (March 2008). "Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia". Cancer. 112 (6): 1296–1305. doi:10.1002/cncr.23270. PMID 18246537. S2CID 205651767.
Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al. (June 2018). "iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL". Blood. 131 (25): 2745–2760. doi:10.1182/blood-2017-09-806398. PMID 29540348. S2CID 206956090.
Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J, et al. (October 2010). "Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial". Lancet. 376 (9747): 1164–1174. doi:10.1016/S0140-6736(10)61381-5. PMID 20888994. S2CID 28834830.
Khan M, Siddiqi T (December 2018). "Targeted Therapies in CLL: Monotherapy Versus Combination Approaches". Current Hematologic Malignancy Reports. 13 (6): 525–533. doi:10.1007/s11899-018-0481-7. PMID 30535947. S2CID 54473182.
Dreger P, Brand R, Hansz J, Milligan D, Corradini P, Finke J, et al. (May 2003). "Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning". Leukemia. 17 (5): 841–848. doi:10.1038/sj.leu.2402905. PMID 12750695. S2CID 10144544.
Molica S, Giannarelli D, Mirabelli R, Levato L, Shanafelt TD (July 2019). "The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis". Leukemia & Lymphoma. 60 (7): 1644–1649. doi:10.1080/10428194.2018.1543882. PMID 30516079. S2CID 54544330.
Bosch F, Dalla-Favera R (November 2019). "Chronic lymphocytic leukaemia: from genetics to treatment". Nature Reviews. Clinical Oncology. 16 (11): 684–701. doi:10.1038/s41571-019-0239-8. PMID 31278397. S2CID 195804409.
Al-Sawaf O, Robrecht S, Bahlo J, Fink AM, Cramer P, von Tresckow J, et al. (October 2017). "Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group". Leukemia. 31 (10): 2251–2253. doi:10.1038/leu.2017.221. PMID 28745332. S2CID 6542508.
Boonhat H, Lin RT (December 2020). "Association between leukemia incidence and mortality and residential petrochemical exposure: A systematic review and meta-analysis". Environment International. 145: 106090. doi:10.1016/j.envint.2020.106090. PMID 32932064. S2CID 221748665.
Farooqui AA, Ashraf A, Farooq TB, Anjum A, Rehman SU, Akbar A, et al. (July 2020). "Novel Targeted Therapies for Chronic Lymphocytic Leukemia in Elderly Patients: A Systematic Review". Clinical Lymphoma, Myeloma & Leukemia. 20 (7): e414–e426. doi:10.1016/j.clml.2020.02.013. PMID 32291235. S2CID 213941348.
Cao JX, Gao WJ, You J, Wu LH, Liu JL, Wang ZX (July 2019). "The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies". Cytotherapy. 21 (7): 769–781. doi:10.1016/j.jcyt.2019.04.005. PMID 31160157. S2CID 174808115.

upenn.edu

uphs.upenn.edu

Auer H (August 10, 2011). "Genetically Modified "Serial Killer" T Cells Obliterate Tumors in Patients with Chronic Lymphocytic Leukemia, Penn Researchers Report". University of Pennsylvania School of Medicine. Retrieved August 12, 2011.

web.archive.org

"Genes and Cancer". Archived from the original on 2021-11-16.
"T Cell Prolymphocytic Leukemia". AccessMedicine. Archived from the original on 2011-07-07. Retrieved 2009-02-04.
"Cancer Facts & Figures 2021" (PDF). American Cancer Society. Archived (PDF) from the original on 2021-01-12.
Bazell R (August 10, 2011). "New leukemia treatment exceeds 'wildest expectations'". NBC News. Archived from the original on March 5, 2013. Retrieved August 12, 2011.

webmd.com

DeNoon DJ (August 10, 2011). "Gene Therapy Cures Adult Leukemia". WebMD. Retrieved August 12, 2011.

worldcat.org

Swerdlow SH (2017). WHO classification of tumours of haematopoietic and lymphoid tissues (Revised 4th ed.). Lyon: World Health Organization,, International Agency for Research on Cancer. p. 219. ISBN 978-92-832-4494-3. OCLC 1011064243.
Papadakis MA, McPhee SJ, Rabow MW, McQuaid KR (2022). Current medical diagnosis & treatment 2022 (Sixty-first ed.). [New York]. ISBN 9781264269389. OCLC 1264228575.{{cite book}}: CS1 maint: location missing publisher (link)
Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J (2018). Harrison's principles of internal medicine (20th ed.). New York. ISBN 978-1-259-64403-0. OCLC 1029074059.{{cite book}}: CS1 maint: location missing publisher (link)

search.worldcat.org

Swerdlow SH (2017). WHO classification of tumours of haematopoietic and lymphoid tissues (Revised 4th ed.). Lyon: World Health Organization,, International Agency for Research on Cancer. p. 219. ISBN 978-92-832-4494-3. OCLC 1011064243.
Papadakis MA, McPhee SJ, Rabow MW, McQuaid KR (2022). Current medical diagnosis & treatment 2022 (Sixty-first ed.). [New York]. ISBN 9781264269389. OCLC 1264228575.{{cite book}}: CS1 maint: location missing publisher (link)
Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J (2018). Harrison's principles of internal medicine (20th ed.). New York. ISBN 978-1-259-64403-0. OCLC 1029074059.{{cite book}}: CS1 maint: location missing publisher (link)